10 Result(s)

Article

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed...

Koos P. J. van Dam, Adriaan G. Volkers, Luuk Wieske… in BMC Infectious Diseases (2023)

Article

Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

Studies have suggested incremental short-term adverse events (AE) after repeated vaccination. In this report, we assessed occurrence and risk factors for short-term AEs following repeated SARS-CoV-2 vaccinatio...

Luuk Wieske, Laura Y. L. Kummer, Koos P. J. van Dam, Eileen W. Stalman… in BMC Medicine (2022)

Article

Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysis

A congenital melanocytic naevus (CMN) is a rare skin condition that can be associated with abnormalities of the central nervous system (CNS). These anomalies can sometimes cause severe complications, and rarel...

Anne C. Fledderus, Anna Linn Widdershoven, Oren Lapid… in Orphanet Journal of Rare Diseases (2022)

Article

Outcome measurement instruments for peripheral vascular malformations and an assessment of the measurement properties: a systematic review

The Outcome measures for vascular malformation (OVAMA) group reached consensus on the core outcome domains for the core outcome set (COS) for peripheral vascular malformations (venous, lymphatic and arterioven...

Sophie E. R. Horbach, Amber P. M. Rongen, Roy G. Elbers… in Quality of Life Research (2020)

Article

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries

Patients with moderate-to-severe atopic eczema (AE) often require photo- or systemic immunomodulatory therapies to induce disease remission and maintain long-term control. The current evidence to guide clinica...

Louise A. A. Gerbens, Aaron E. Boyce, Dmitri Wall, Sebastien Barbarot… in Trials (2017)

Article

Achieving consensus over the assessment of clinical signs in eczema trials

Kim S Thomas, Jochen Schmitt, Phyllis I Spuls, Eric Simpson, Masutaka Furue… in Trials (2015)

Article

The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial

Interest in health-related quality of life (HRQoL) outcome research in dermatology is increasing, especially in the systemic treatment of psoriasis with biologic agents. In other specialties, such as oncology,...

Cecilia AC Prinsen, Phyllis I Spuls, Mirjam AG Sprangers, Menno A de Rie… in Trials (2012)